Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Imagabalin

Generic Name: Imagabalin

Drug Type: Small Molecule

Chemical Formula: C_₉H_₁₉NO_₂

CAS Number: 610300-07-7

Unique Ingredient Identifier: NDG6931B7H

Overview

Imagabalin has been investigated in Generalized Anxiety Disorder.

Background

Imagabalin has been investigated in Generalized Anxiety Disorder.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder

Phase 2

Completed

Posted: 2009/06/16

Sponsor:Pfizer

ID:NCT00921063

A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects

Phase 1

Withdrawn

Posted: 2009/01/12

Sponsor:Pfizer

ID:NCT00820794

Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time

Phase 1

Terminated

Posted: 2008/12/17

Sponsor:Pfizer

ID:NCT00809536

Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

Phase 1

Terminated

Posted: 2008/12/02

Sponsor:Pfizer

ID:NCT00800280

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

Phase 3

Withdrawn

Posted: 2008/08/20

Sponsor:Pfizer

ID:NCT00738738

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy